Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end markets Net proceeds from the saleRead More…
Lifecore to Manufacture New Innovative Drug for Treatment of Postoperative Pain Following Customer’s FDA Approval
Lifecore Expands its Aseptic Production of Pharmaceutical Drugs CHASKA, Minn., May 17, 2021 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc., a fully-owned subsidiary of LandecRead More…
Landec’s Lifecore Invests in CDMO Capabilities to Support Expansion into New Drug Applications
Landec Raises Fiscal Year 2017 Capital Spend Guidance from $25 million to approximately $30 million MENLO PARK, Calif., Oct. 12,Read More…